These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia. Fishwild DM, Aberle S, Bernhard SL, Kung AH. Cancer Res; 1992 Jun 01; 52(11):3056-62. PubMed ID: 1375534 [Abstract] [Full Text] [Related]
16. [Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]. Morimoto C, Ohnuma K. Nihon Rinsho; 2012 Dec 15; 70(12):2177-82. PubMed ID: 23259393 [Abstract] [Full Text] [Related]
17. [CD7 positive undifferenciated leukemia/lymphoma associated with leukemic pericarditis]. Ochi K, Amano M, Soda Y, Togawa A, Takaku F. Rinsho Ketsueki; 1994 Jul 15; 35(7):665-9. PubMed ID: 7520512 [Abstract] [Full Text] [Related]
18. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen. Sheibani K, Battifora H, Burke JS. Am J Pathol; 1986 May 15; 123(2):212-9. PubMed ID: 2422942 [Abstract] [Full Text] [Related]
19. [Immunological aspects of asbestos-related diseases]. Kanceljak-Macan B. Arh Hig Rada Toksikol; 2009 Nov 15; 60 Suppl():45-50. PubMed ID: 20853778 [Abstract] [Full Text] [Related]
20. CD7 is associated with CD3 and CD45 on human T cells. Lazarovits AI, Osman N, Le Feuvre CE, Ley SC, Crumpton MJ. J Immunol; 1994 Nov 01; 153(9):3956-66. PubMed ID: 7523512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]